BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30

• Pharm Country

  Regenicin, Inc. Announces Press and Investor Conference, NASDAQ MarketSite, Times Square

  September 3, 2010

   · 

  1 min read
• Long-term Bleeding While on Dual Antiplatelet Therapy Worsens Outcome

  September 3, 2010

   · 

  1 min read
• No Advantage for Olmesartan in Paroxysmal Atrial Fibrillation

  September 3, 2010

   · 

  1 min read
• Studies Assess Heart Failure With Normal Ejection Fraction

  September 3, 2010

   · 

  1 min read
• Dual-Chamber Pacing Shows Clinical Benefits Over Single-Lead Pacing in Patients With Sick Sinus Syndrome

  September 3, 2010

   · 

  1 min read
• RESPONSE: Nurse-led Prevention Program Lowers Cardiac Risk in CAD Patients

  September 3, 2010

   · 

  1 min read
• Early Recurrent Ischemic Stroke Can Complicate Thrombolysis

  September 3, 2010

   · 

  1 min read
• Epidural Catheter-Linked Infections Rare In Children

  September 3, 2010

   · 

  1 min read
• Policy

  WuXi PharmaTech Co., Ltd. Subsidiary Passes ISO Tests

  September 3, 2010

   · 

  1 min read
• Business

  Santhera Pharmaceuticals AG and Ipsen Enter into Licensing Agreement for Fipamezole for the Treatment of Dyskinesia in Parkinson’s Disease; Upfront Payment of 13 Million Euros With Another Milestones of Up To 128 Million Euros

  September 3, 2010

   · 

  7 min read